Compared to hospitals not participating in BPCI, Medicare episode payments for lower extremity joint replacements declined $1,166 more at BPCI-participating hospitals, according to the study. The researchers attribute this decline primarily to reduced use of institutional post-acute care.
They found no statistical differences in quality measures between BPCI participants and non-participants, which included 30- and 90-day unplanned readmissions, 30- and 90-day emergency department visits and 30- and 90-day post-discharge mortality.
CMS also released its second annual evaluation report for Models 2-4 of BPCI Monday.
More articles on finance:
Erlanger reports net surplus, gives 3,700 employees bonuses
West Virginia has saved more than $1M by enrolling inmates in Medicaid
Fitch places Community Health Systems’ ratings on evolving watch
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
